Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.27
Delayed Data
As of 2:08pm ET
 -0.02 / -1.55%
Today’s Change
1.19
Today|||52-Week Range
1.89
-8.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-34.2M-42.1M-29.8M-35.4M
 
 
 
 
 
Depreciation652.0K908.0K1.1M986.0K
 
 
 
 
 
Total Other Cash Flow4.1M2.8M5.1M6.2M
 
 
 
 
 
Funds From Operations-29.4M-38.4M-23.6M-28.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.0M-2.5M-2.6M89.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-26.5M-35.9M-20.9M-28.3M
 
 
 
 
 
 
InvestingCapital Expenditures-912.0K-1.6M-853.0K-755.0K
 
 
 
 
 
Other Investing - Uses-435.0K0.000.000.00
 
 
Other Investing - Sources0.00383.0K102.0K--
 
 
 
Net Cash Flow Investing-1.3M-1.2M-751.0K-2.5M
 
 
 
 
 
 
FinancingShort Term Borrowings-2.1M0.000.000.00
 
 
Long Term Borrowings0.000.0014.7M0.00
 
 
Long Term Debt Reduction0.00-1.4M-16.1M-32.0K
 
 
 
 
Net Proceeds Stock Sale33.3M33.4M40.2M73.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.00-232.0K
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing31.2M32.0M38.8M73.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash3.4M-5.0M17.2M42.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account